Search results for "Replication"

showing 10 items of 489 documents

Hepatitis viruses: live and let die.

2007

Viral hepatitis is a diffuse inflammatory reaction of the liver caused by hepatotropic viruses. Among the hepatitis viruses, only hepatitis B virus and hepatitis C virus are able to persist in the host and cause chronic hepatitis. In the course of persistent infection, inflammation forms the pathogenetic basis of chronic hepatitis that can lead to nodular fibrosis, which can progress to cirrhosis and, eventually, hepatocellular carcinoma (HCC). Of the different antiviral defense systems employed by the host, apoptosis significantly contributes to the prevention of viral replication, dissemination, and persistence. Pathomorphologic studies have shown acidophilic bodies and hepatocyte dropout…

Hepatitis B virusHepatitis B virusHepatologyHepatitis C virusViral pathogenesisApoptosisHepacivirusHepatitis BBiologymedicine.diseasemedicine.disease_causeHepatitis BVirologyHepatitis CLiver diseaseViral replicationCytopathogenic Effect ViralLiverHepatocellular carcinomaImmunologymedicineHepatocytesAnimalsHumansViral hepatitisLiver international : official journal of the International Association for the Study of the Liver
researchProduct

Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin.

2007

ABSTRACT Hepatitis B virus (HBV) is an enveloped DNA virus that presumably buds at intracellular membranes of infected cells. HBV budding involves two endocytic host proteins, the ubiquitin-interacting adaptor γ2-adaptin and the Nedd4 ubiquitin ligase. Here, we demonstrate that HBV release also requires the cellular machinery that generates internal vesicles of multivesicular bodies (MVBs). In order to perturb the MVB machinery in HBV-replicating liver cells, we used ectopic expression of dominant-negative mutants of different MVB components, like the ESCRT-III complex-forming CHMP proteins and the Vps4 ATPases. Upon coexpression of mutated CHMP3, CHMP4B, or CHMP4C forms, as well as of ATPa…

Hepatitis B virusVacuolar Proton-Translocating ATPasesEndosomeImmunologyEndocytic cycleVesicular Transport Proteinsmacromolecular substancesEndosomesmedicine.disease_causeMicrobiologyESCRTVirusCell LineViral ProteinsVirologymedicineHumansAdaptor Protein Complex gamma SubunitsHepatitis B virusAdenosine TriphosphatasesMicroscopy ConfocalbiologyEndosomal Sorting Complexes Required for TransportVirus AssemblyDNA virusMolecular biologyUbiquitin ligaseCell biologyGenome Replication and Regulation of Viral Gene ExpressionMicroscopy FluorescenceInsect Sciencebiology.proteinHepatocytesATPases Associated with Diverse Cellular ActivitiesEctopic expressionJournal of virology
researchProduct

Myristylation is involved in intracellular retention of hepatitis B virus envelope proteins

1991

The envelope of hepatitis B virus contains three related proteins, one of which is myristylated. The nonmyristylated small and middle protein are assembled into empty envelope particles which are secreted from cells, whereas the myristylated large envelope protein is mainly found in complete virions and is not secreted in the absence of the nucleocapsid. The block to secretion can be partially overcome by mutation or deletion of the myristylation site. Creation of a myristyl attachment site in the small protein impairs the secretion of empty envelope particles but not their intracellular assembly. Myristylation may therefore play a crucial role in hepatitis B virus replication by channeling…

Hepatitis B virusvirusesDNA Mutational AnalysisImmunologyIn Vitro TechniquesBiologyVirus Replicationmedicine.disease_causeMyristic AcidMicrobiologyVirusStructure-Activity RelationshipCapsidViral Envelope ProteinsViral envelopeVirologymedicineHumansSecretionProtein PrecursorsHepatitis B virusMutationHepatitis B Surface Antigensbiology.organism_classificationVirologyCell CompartmentationMolecular WeightCapsidHepadnaviridaeViral replicationInsect ScienceMyristic AcidsProtein Processing Post-TranslationalResearch ArticleJournal of Virology
researchProduct

Quantitation of HCV-replication using one-step competitive reverse transcription-polymerase chain reaction and a solid phase, colorimetric detection …

1994

A solid phase assay for the colorimetric detection of competitively amplified HCV-cDNA has been established and used to investigate clinical samples from patients with chronic hepatitis. The assay is based on the reduction in the amplification of an hepatitis C virus-related competitor molecule by wild-type hepatitis C virus during polymerase chain reaction. The internal standard contains a lac operator sequence, allowing the amount of amplified competitor to be determined using a lac I-repressor/beta-galactosidase fusion protein. The reduction in the amplification of competitor is dependent upon the concentration of HCV-RNA in the original sample. External hepatitis C virus wild-type stand…

Hepatitis C virusHepacivirusBiologymedicine.disease_causeVirus ReplicationPolymerase Chain ReactionSensitivity and SpecificityViruslaw.inventionFlaviviridaelawmedicineHumansPolymerase chain reactionHepatologyGene AmplificationHepatitis CAmpliconmedicine.diseasebiology.organism_classificationVirologyMolecular biologyHepatitis CReverse transcription polymerase chain reactionTiterRNA ViralColorimetryJournal of hepatology
researchProduct

Characterization of cell lines carrying self-replicating hepatitis C virus RNAs.

2001

ABSTRACT Subgenomic selectable RNAs of the hepatitis C virus (HCV) have recently been shown to self-replicate to high levels in the human hepatoma cell line Huh-7 (V. Lohmann, F. Körner, J. O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager, Science 285:110–113, 1999). Taking advantage of this cell culture system that allows analyses of the interplay between HCV replication and the host cell, in this study we characterized two replicon-harboring cell lines that have been cultivated for more than 1 year. During this time, we observed no signs of cytopathogenicity such as reduction of growth rates or ultrastructural changes. High levels of HCV RNAs were preserved in cells passaged under…

Hepatitis C virusImmunoelectron microscopyImmunologyHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeVirus ReplicationMicrobiologyViral ProteinsVirologymedicineTumor Cells CulturedHumansRepliconPhosphorylationNS5ARNAVirologyMolecular biologyVirus-Cell InteractionsNS2-3 proteaseViral replicationCell cultureInsect ScienceRNA ViralRepliconJournal of virology
researchProduct

Sequences in the 5′ Nontranslated Region of Hepatitis C Virus Required for RNA Replication

2001

ABSTRACT Sequences in the 5′ and 3′ termini of plus-strand RNA viruses harbor cis -acting elements important for efficient translation and replication. In case of the hepatitis C virus (HCV), a plus-strand RNA virus of the family Flaviviridae , a 341-nucleotide-long nontranslated region (NTR) is located at the 5′ end of the genome. This sequence contains an internal ribosome entry site (IRES) that is located downstream of an about 40-nucleotide-long sequence of unknown function. By using our recently developed HCV replicon system, we mapped and characterized the sequences in the 5′ NTR required for RNA replication. We show that deletions introduced into the 5′ terminal 40 nucleotides abolis…

Hepatitis C virusImmunologyRNA-dependent RNA polymeraseReplicationHepacivirusmedicine.disease_causeOrigin of replicationMicrobiologyVirologymedicineTumor Cells CulturedHumansRepliconGeneticsbiologyRNARNA virusbiology.organism_classificationVirologyNS2-3 proteaseInternal ribosome entry siteInsect ScienceProtein BiosynthesisRNA ViralReplicon5' Untranslated Regions
researchProduct

Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

2001

ABSTRACT As an initial approach to studying the molecular replication mechanisms of hepatitis C virus (HCV), a major causative agent of acute and chronic liver disease, we have recently developed selectable self-replicating RNAs. These replicons lacked the region encoding the structural proteins and instead carried the gene encoding the neomycin phosphotransferase. Although the replication levels of these RNAs within selected cells were high, the number of G418-resistant colonies was reproducibly low. In a search for the reason, we performed a detailed analysis of replicating HCV RNAs and identified several adaptive mutations enhancing the efficiency of colony formation by several orders of…

Hepatitis C virusImmunologyReplicationHepacivirusBiologyViral Nonstructural Proteinsmedicine.disease_causeMicrobiologychemistry.chemical_compoundVirologymedicineTumor Cells CulturedHumansRepliconAmino AcidsNS5BGene3' Untranslated RegionsGeneticsMutationThree prime untranslated regionRNAVirologyAdaptation PhysiologicalchemistryCell cultureInsect ScienceMutationRNA ViralRepliconJournal of virology
researchProduct

Mutual antagonism between clock protein Period2 and hepatitis C virus replication in hepatocytes.

2013

Background: Hepatitis C virus (HCV) infects approximately 3% of the world population and is the leading cause of liver disease, impacting hepatocyte metabolism, depending on virus genotype. Hepatic metabolic functions show rhythmic fluctuations with 24-h periodicity (circadian), driven by molecular clockworks ticking through translational-transcriptional feedback loops, operated by a set of genes, called clock genes, encoding circadian proteins. Disruption of biologic clocks is implicated in a variety of disorders including fatty liver disease, obesity and diabetes. The relation between HCV replication and the circadian clock is unknown. Methods: We investigated the relationship between HCV…

Hepatitis C circadian clock viral replication interferon signaling.
researchProduct

Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis.

2013

Antitumor and antiviral properties of the antimalaria drug artemisinin from Artemisia annua have been reported. Novel artemisinin derivatives (AD1-AD8) have been synthesized and evaluated using in vitro models of liver/colon cancer and viral hepatitis B and C. Cell viability assays after treating human cell lines from hepatoblastoma (HepG2), hepatocarcinoma (SK-HEP-1), and colon adenocarcinoma (LS174T) with AD1-AD8 for a short (6h) and long (72h) period revealed that AD5 combined low acute toxicity together with high antiproliferative effect (IC50=1-5μM). Since iron-mediated activation of peroxide bond is involved in artemisinin antimalarial activity, the effect of iron(II)-glycine sulfate …

Hepatitis Viral HumanCell SurvivalvirusesHepatitis C virusClinical BiochemistryArtemisia annuaPharmaceutical SciencePharmacologymedicine.disease_causeVirus ReplicationBiochemistrychemistry.chemical_compoundCell Line TumorDrug DiscoverymedicineAnimalsHumansArtemisininMolecular BiologyCell ProliferationHepatitis B virusHepatitisbiologyMolecular StructureChemistryOrganic ChemistryLiver Neoplasmsbiology.organism_classificationmedicine.diseaseVirologyArtemisininsColonic NeoplasmsMolecular MedicineLiver cancerViral hepatitisHeminmedicine.drugBioorganicmedicinal chemistry
researchProduct

Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs

2002

Persistent infection with hepatitis C virus (HCV) is a major cause of chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. All treatments known so far rely on the antiviral activity of interferon alfa (IFN-alpha) that is given alone or in combination with ribavirin. Unfortunately, only a fraction of the patients clear the virus during therapy and for those who do not respond there is currently no alternative treatment. Selectable subgenomic HCV RNAs (replicons) have been recently used to investigate the effect of IFN-alpha on HCV replication. However, it has not yet been analyzed whether other cytokines also play a role in the innate immune response against HCV. Here we show th…

HepatologyHepatitis C virusvirus diseasesBiologymedicine.disease_causeVirologydigestive system diseasesVirusNS2-3 proteaseCell killingViral replicationmedicineInterferon gammaInterferon alfamedicine.drugSubgenomic mRNAHepatology
researchProduct